{
  "pmid": "40557729",
  "title": "Deucravacitinib: Long-term safety and efficacy reaffirm its place in the psoriasis treatment landscape.",
  "abstract": "",
  "pub_date": "2025-07",
  "publication_types": [
    "Journal Article"
  ],
  "affiliations": [
    "Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.",
    "Faculty of Science, University of Zürich, Zurich, Switzerland.",
    "Department of Dermatology, Trakya University Faculty of Medicine, Edirne, Türkiye.",
    "Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.",
    "Faculty of Medicine, University of Zürich, Zurich, Switzerland."
  ],
  "url": "https://pubmed.ncbi.nlm.nih.gov/40557729/",
  "snapshot_id": "2026-02-12T15-11-42Z",
  "ingested_at": "2026-02-12T15:11:45.771210+00:00"
}